Bruker Corp
NASDAQ:BRKR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
48.25
94.27
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bruker Corp
Wall Street
Price Targets
BRKR Price Targets Summary
Bruker Corp
According to Wall Street analysts, the average 1-year price target for
BRKR
is 73.83 USD
with a low forecast of 54.54 USD and a high forecast of 89.25 USD.
BRKR Last Price Targets
Bruker Corp
The latest public price target was made on Sep 23, 2024 by
Patrick Donnelly
from
Citigroup
,
who expects
BRKR
stock to
rise by 39%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Patrick Donnelly
Citigroup
|
80
USD
Upside 39% |
3 months ago
Sep 23, 2024
|
Citi Reiterates Buy Rating on Bruker (BRKR)
StreetInsider
|
Brandon Couillard
Wells Fargo
|
78
USD
Upside 36% |
3 months ago
Aug 27, 2024
|
Bruker initiated with an Overweight at Wells Fargo
TheFly
|
Daniel Arias
Stifel Nicolaus
|
77
USD
Upside 34% |
7 months ago
May 20, 2024
|
Bruker (BRKR) PT Lowered to $77 at Stifel
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BRKR's stock price target?
Price Target
73.83
USD
According to Wall Street analysts, the average 1-year price target for
BRKR
is 73.83 USD
with a low forecast of 54.54 USD and a high forecast of 89.25 USD.
What is Bruker Corp's Revenue forecast?
Projected CAGR
9%
For the last 8 years the
compound annual growth rate for
Bruker Corp's revenue is
8%.
The projected
CAGR
for the next 4 years is
9%.
What is Bruker Corp's Operating Income forecast?
Projected CAGR
13%
For the last 8 years the
compound annual growth rate for
Bruker Corp's operating income is
15%.
The projected
CAGR
for the next 4 years is
13%.
What is Bruker Corp's Net Income forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Bruker Corp's net income is
20%.
The projected
CAGR
for the next 4 years is
7%.
You don't have any saved screeners yet
